A PYMNTS Company

US: Novartis animal unit buyout creates second-place leader

By  |  April 23, 2014

Eli Lilly-owned Elanco has inked a deal to acquire pharmaceutical giant Novartis’s Animal Health operations, a deal set to create the world’s second-largest animal health conglomerate.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The deal, estimated at $5.4 billion, was inked by the firms in an all-cash transaction, including debt.

    Elanco president Jeff Simmons called the merger “the most transformational milestone” in the company’s history.

    The deal will remain subject to regulatory clearance, say reports.

    Full Content: Hoosier Ag Today

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.